The patient and provider interviews identified a total of 83 ADRs, compared with 1 ADR identified by the passive reporting system. When providers were made aware of the ADRs they had not ...

Recent research has focused on identifying barriers to reporting and exploring innovative solutions to enhance patient involvement in ADR reporting. One significant area of research has been the ...

Background: Spontaneous adverse drug reaction (ADR) reporting is the cornerstone of pharmacovigilance. ADR reporting with Yellow Cards has tremendously improved pharmacovigilance of drugs in many ...

PDD Holdings Inc. Sponsored ADR (PDD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the ...

This was the ADR's seventh consecutive day of gains.

This was the ADR's second consecutive day of gains.

Bernstein analyst Eunice Lee maintained a Hold rating on XPeng, Inc. ADR (XPEV – Research Report) yesterday and set a price target of $14.00.

Veritext, the court-reporting business that is steadily ‘rolling-up’ a mass of smaller groups in the US, is now pushing ...

In a report released today, Ming-Hsun Lee from Bank of America Securities maintained a Buy rating on XPeng, Inc. ADR (XPEV – Research Report), ...